Navigation

Chemical

The Global Chemical Group consists of an experienced team of highly trained professionals who are focused on all sectors of the chemical industry in order to help our clients capitalize on the changing sector.

The chemical group is recognized as a leader in all product categories, from M&A advisory to capital-raising.

The group has forged strong relationships with the top companies in the sector and has advised on numerous landmark transactions including:

  • Financial Advisor to Union Carbide on its $11.6 billion merger with Dow Chemical.
  • Financial Advisor to AstraZeneca on the spin-off and merger of its agrochemicals business with the agribusiness of Novartis to form Syngenta.
  • Financial Advisor to DuPont on its $7.7 billion acquisition of Pioneer Hi-Bred.
  • Financial Advisor to W.R. Grace on its $6 billion merger of its packaging business with Sealed Air.
  • Financial Advisor to Hoechst on its $2.8 billion demerger of Celanese. Financial Advisor to Bayer on its $2.5 billion acquisition of Lyondell's polyols business.
  • Financial Advisor to Courtaulds on its £1.8 billion sale to Akzo-Nobel.
  • Financial Advisor to Invitrogen on its $1.9 billion acquisition of Dexter.
  • Financial Advisor to Sasol on its $1.2 billion acquisition of Condea.
  • Financial Advisor to Bush Boake Allen on its $1 billion sale to IFF.

Demonstrating our multi-product capabilities, the group has provided acquisition financing packages for a number of high-profile transactions including:

  • Financial Advisor and Lead Financial Arranger on OM Group's €1.2 billion acquisition of Degussa's dmc2 business.
  • Private Equity Investor and Lead Financial Arranger on the acquisition of BF Goodrich's Performance Materials business.
  • Syndication Agent and Joint Bookrunning Manager on Lyondell's $7 billion financing related to the acquisition of ARCO Chemical, including a $2.4 billion high yield offering, a $765 million equity offering and $3.8 billion of bank financing.
  • Financial Advisor, Sole Arranger and Sole Lead Manager to Ciba on its £1.4 billion acquisition and financing of Allied Colloids.
  • Financial Advisor to Praxair on its $2.2 billion acquisition of CBI. Lead Arranger in a subsequent $476 million equity offering.

We have been the lead underwriter on some of the industry's most significant debt and equity transactions including:

  • Sole Lead Manager on Hercules $400 million high-yield offering and $375 million syndicated loan offering.
  • Sole Financial Advisor and Listing Agent on Givaudan's CHF4.4 billion spin-off from Roche.
  • Joint Bookrunning Lead Manager on Rhône-Poulenc's €1.2 billion secondary offering of Rhodia and €1.0 billion exchangeable notes offering.
  • Joint Manager in Rhodia's 27.6% spin-off from Rhône-Poulenc.

Secondary Content